A phase Ib/II trial of CA4P in combination with carboplatin and paclitaxel chemotherapy in patients with advanced ovarian cancer and other solid tumors commonly treated with carboplatin.

Trial Profile

A phase Ib/II trial of CA4P in combination with carboplatin and paclitaxel chemotherapy in patients with advanced ovarian cancer and other solid tumors commonly treated with carboplatin.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Fosbretabulin (Primary) ; Carboplatin; Paclitaxel
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors OXiGENE
  • Most Recent Events

    • 11 Apr 2017 Last checked against ISRCTN: Current Controlled Trials.
    • 30 Jan 2014 According to United Kingdom Clinical Research Network report, the accruel to date is 104%
    • 01 Apr 2010 New source identified and integrated (ISRCTN: Current Controlled Trials record no. 57858356).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top